|
Temple University researchers have developed a new drug that could
potentially treat all forms of Gleevec-resistant chronic myelogenous leukemia
(CML). Their work is published in this week's early edition of Proceedings of
the National Academy of Sciences...Recently, two experimental drugs were found
to be effective in circumventing some but not all forms of Gleevec resistance.
Both, for instance, failed to block the activity of a mutant BCR-ABL, called
T315I, which is one of the more predominant mutations seen in Gleevec-resistant
patients. Reddy and his research team sought instead to develop a drug that
would circumvent all of the mutations and therefore all forms of
resistance....when patients become resistant to Gleevec, our drug kills 100
percent of the cancer cells," said Reddy.
New! Sign up for local CML support group meetings in your local community at http://cml.meetup.com Apply for Commercial Real Estate loans online and submit your deal to dozens of hungry lenders in just minutes. Loan programs for all types of business and commercial real estate. Apply anytime at http://realestatezoo.com CML (Chronic Myelogenous Leukemia Support List) --------------------------------- Part Of CMLHope.Com An International Community Of CML Patients For more information: http://cmlhope.com Post Message: [email protected] Subscribe: [EMAIL PROTECTED] Unsubscribe: [EMAIL PROTECTED] Change To No Mail/Web: [EMAIL PROTECTED] Change To Digest: [EMAIL PROTECTED] Change To Email: [EMAIL PROTECTED] List Help: [EMAIL PROTECTED] CML Group Web Site http://groups.yahoo.com/group/CML Yahoo! Groups Links
|
- [CML] New Drug ON012380 Overcomes All Known CML Mutations Rob
